Sean D Keohane is President and CEO of CABOT CORP. Currently has a direct ownership of 361,518 shares of CBT, which is worth approximately $39.9 Million. The most recent transaction as insider was on Nov 18, 2024, when has been sold 20,631 shares (Common Stock) at a price of $108.82 per share, resulting in proceeds of $2,245,065. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 362K
9.16% 3M change
9.16% 12M change
Total Value Held $39.9 Million

Sean D Keohane Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 18 2024
SELL
Payment of exercise price or tax liability
$2,245,065 $108.82 p/Share
20,631 Reduced 5.4%
361,518 Common Stock
Nov 18 2024
BUY
Grant, award, or other acquisition
-
45,842 Added 10.71%
382,149 Common Stock
Nov 12 2024
SELL
Payment of exercise price or tax liability
$1,330,672 $112.54 p/Share
11,824 Reduced 3.4%
336,307 Common Stock
Nov 08 2024
BUY
Grant, award, or other acquisition
-
16,957 Added 4.64%
348,131 Common Stock
Sep 03 2024
SELL
Open market or private sale
$2,606,785 $101.76 p/Share
25,617 Reduced 7.18%
331,174 Common Stock
Sep 03 2024
BUY
Exercise of conversion of derivative security
$1,012,896 $39.54 p/Share
25,617 Added 6.7%
356,791 Common Stock
Mar 01 2024
SELL
Open market or private sale
$1,526,416 $85.48 p/Share
17,857 Reduced 5.12%
331,174 Common Stock
Mar 01 2024
BUY
Exercise of conversion of derivative security
$821,957 $46.03 p/Share
17,857 Added 4.87%
349,031 Common Stock
Nov 20 2023
SELL
Payment of exercise price or tax liability
$3,056,325 $77.89 p/Share
39,239 Reduced 10.59%
331,174 Common Stock
Nov 20 2023
BUY
Grant, award, or other acquisition
-
37,402 Added 9.17%
370,413 Common Stock
Nov 13 2023
SELL
Payment of exercise price or tax liability
$1,245,803 $74.08 p/Share
16,817 Reduced 4.81%
333,011 Common Stock
Nov 10 2023
BUY
Grant, award, or other acquisition
-
25,000 Added 6.67%
349,828 Common Stock
Nov 21 2022
SELL
Payment of exercise price or tax liability
$1,223,178 $71.51 p/Share
17,105 Reduced 5.0%
324,828 Common Stock
Nov 21 2022
BUY
Grant, award, or other acquisition
-
66,196 Added 16.22%
341,933 Common Stock
Nov 11 2022
BUY
Grant, award, or other acquisition
-
21,939 Added 7.37%
275,737 Common Stock
Nov 08 2022
SELL
Payment of exercise price or tax liability
$835,234 $70.07 p/Share
11,920 Reduced 4.49%
253,798 Common Stock
May 24 2022
SELL
Open market or private sale
$989,209 $69.19 p/Share
14,297 Reduced 5.11%
265,718 Common Stock
May 24 2022
BUY
Exercise of conversion of derivative security
$680,823 $47.62 p/Share
14,297 Added 4.86%
280,015 Common Stock
Nov 22 2021
SELL
Payment of exercise price or tax liability
$554,188 $59.68 p/Share
9,286 Reduced 3.38%
265,718 Common Stock
Nov 22 2021
BUY
Grant, award, or other acquisition
-
57,673 Added 17.34%
275,004 Common Stock
Nov 12 2021
BUY
Grant, award, or other acquisition
-
24,455 Added 10.11%
217,331 Common Stock
Nov 09 2021
SELL
Payment of exercise price or tax liability
$688,922 $57.53 p/Share
11,975 Reduced 5.85%
192,876 Common Stock
Nov 13 2020
BUY
Grant, award, or other acquisition
-
34,781 Added 14.51%
204,851 Common Stock
Nov 10 2020
SELL
Payment of exercise price or tax liability
$807,466 $43.18 p/Share
18,700 Reduced 9.91%
170,070 Common Stock

Also insider at

CC
Chemours Co Basic Materials
SDK

Sean D Keohane

President and CEO
Boston, MA

Track Institutional and Insider Activities on CBT

Follow CABOT CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CBT shares.

Notify only if

Insider Trading

Get notified when an Cabot Corp insider buys or sells CBT shares.

Notify only if

News

Receive news related to CABOT CORP

Track Activities on CBT